Would like to think that the numerous DSMB hurdles roxa has cleared and accumulation of patient years on the drug would give some degree of comfort for roxa on the safety front. Doesn't guarantee anything at all of course, but hopefully some degree of comfort. Much more so than the AKBA drug I would think.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.